11/27
08:42 am
ctor
Citius Oncology, Inc. (NASDAQ: CTOR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $3.00 price target on the stock.
Medium
Report
Citius Oncology, Inc. (NASDAQ: CTOR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $3.00 price target on the stock.